Results for tag: "Ditazole"

Ditazole is a type of hematological drug used to treat a variety of blood disorders, including anemia, thrombocytopenia, and leukopenia. It is a combination of two active ingredients, dithranol and thiamphenicol, which work together to reduce the production of red blood cells and platelets. Ditazole is available in both oral and injectable forms, and is typically prescribed for short-term use. The Ditazole market is highly competitive, with a number of pharmaceutical companies offering their own versions of the drug. These companies are focused on developing new formulations and delivery systems to improve the efficacy and safety of the drug. Additionally, they are investing in research and development to create new indications for the drug, as well as to expand its use in other hematological disorders. Some of the companies in the Ditazole market include Pfizer, Novartis, Merck, Sanofi, and GlaxoSmithKline. Show Less Read more